Atasoy Ali Riza, Ciftci Ihsan Hakki, Petek Mustafa
Department of Medical Microbiology, Sakarya University Faculty of Medicine Sakarya, Turkey.
Environmental Engineering, Fatih University Faculty of Engineering İstanbul, Turkey.
Int J Clin Exp Med. 2015 Feb 15;8(2):2874-80. eCollection 2015.
Enzymatic modification of aminoglycosides by nucleotidyltransferases, acetyltransferases and/or phosphotransferases accounts for the majority of aminoglycoside-resistant Acinetobacter isolates. In this study, we investigated the relationship between aminoglycoside resistance and the presence of aminoglycoside-modifying enzymes in Acinetobacter baumannii clinical isolate groups with different resistance profiles. Thirty-two clinical A. baumannii isolates were included in this study. Acinetobacter isolates were divided into 4 groups according to results of susceptibility testing. The presence of genes encoding the following aminoglycoside-modifying enzymes; aph (3')-V1, aph (3')-Ia, aac (3)-Ia, aac (3) IIa, aac (6')-Ih, aac (6')-Ib and ant (2')-Ia responsible for resistance was investigated by PCR in all strains. The acetyltransferase (aac (6')-Ib, aac (3)-Ia) and phosphotransferase (aph (3')-Ia) gene regions were identified in the first group, which comprised nine imipenem, meropenem, and gentamicin-resistant isolates. The acetyltransferase (aac (6')-Ib, aac (3)-Ia), phosphotransferase (aph (3')-VI) and nucleotidyltransferase (ant2-Ia) gene regions were identified in the second group, which was composed of nine imipenem-resistant, meropenem-resistant and gentamicin-sensitive isolates. The acetyltransferase (aac (3)-Ia) and phosphotransferase (aph (3')-Ia) regions were identified in the fourth group, which comprised eight imipenem-sensitive, meropenem-sensitive and gentamicin-resistant isolates. Modifying enzyme gene regions were not detected in the third group, which was composed of six imipenem, meropenem and gentamicin-sensitive isolates. Our data are consistent with previous reports, with the exception of four isolates. Both acetyltransferases and phosphotransferases were widespread in A. baumannii clinical isolates in our study. However, the presence of the enzyme alone is insufficient to explain the resistance rates. Therefore, the association between the development of resistance and the presence of the enzyme and other components should be investigated further.
氨基糖苷类药物经核苷酸转移酶、乙酰转移酶和/或磷酸转移酶进行酶修饰,是大多数耐氨基糖苷类鲍曼不动杆菌分离株耐药的原因。在本研究中,我们调查了具有不同耐药谱的鲍曼不动杆菌临床分离株组中,氨基糖苷类耐药性与氨基糖苷类修饰酶的存在之间的关系。本研究纳入了32株鲍曼不动杆菌临床分离株。根据药敏试验结果,将鲍曼不动杆菌分离株分为4组。通过PCR检测了所有菌株中编码以下导致耐药的氨基糖苷类修饰酶的基因的存在情况:aph(3')-V1、aph(3')-Ia、aac(3)-Ia、aac(3)IIa、aac(6')-Ih、aac(6')-Ib和ant(2')-Ia。在第一组中鉴定出了乙酰转移酶(aac(6')-Ib、aac(3)-Ia)和磷酸转移酶(aph(3')-Ia)基因区域,该组包括9株对亚胺培南、美罗培南和庆大霉素耐药的分离株。在第二组中鉴定出了乙酰转移酶(aac(6')-Ib、aac(3)-Ia)、磷酸转移酶(aph(3')-VI)和核苷酸转移酶(ant2-Ia)基因区域,该组由9株对亚胺培南耐药、对美罗培南耐药且对庆大霉素敏感的分离株组成。在第四组中鉴定出了乙酰转移酶(aac(3)-Ia)和磷酸转移酶(aph(3')-Ia)区域,该组包括8株对亚胺培南敏感、对美罗培南敏感且对庆大霉素耐药的分离株。在由6株对亚胺培南、美罗培南和庆大霉素敏感的分离株组成的第三组中,未检测到修饰酶基因区域。我们的数据与之前的报道一致,但有4株分离株除外。在我们的研究中,乙酰转移酶和磷酸转移酶在鲍曼不动杆菌临床分离株中广泛存在。然而,仅酶的存在不足以解释耐药率。因此,耐药性的产生与酶及其他成分的存在之间的关联应进一步研究。